Swiss SOS MoCA - DCI Study

NCT03032471 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2022-05-12

No results posted yet for this study

Summary

The primary objective of this multicenter observational study is to determine the effect size of the relationship between DCI and neuropsychological impairment 14-28 days and 3 months after aSAH.

Secondary objectives are the feasibility to administer and the validity of the MoCA in an intensive care unit setting, as well as the test/retest reliability of the MoCA in patients with acute brain damage in absence of aSAH.

Conditions

  • Subarachnoid Hemorrhage
  • Delayed Cerebral Ischemia
  • Stroke
  • Complication
  • Cognitive Impairment
  • Cognitive Deficit
  • Cognitive Deterioration
  • Cognitive Deficits Following Cerebral Infarction

Interventions

OTHER

There is no intervention for this study. Patients are allocated to the study groups based on whether or not DCI occurs.

There is no intervention for this study. Patients are allocated to the study groups based on whether or not DCI occurs.

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER
  • Département des Neurosciences cliniques, Service de Neurochirurgie, Hôpitaux Universitaires de Genève

    collaborator UNKNOWN
  • Primario Neurochirurgia, EOC Ospedale Regionale di Lugano - Civico e Italiano

    collaborator UNKNOWN
  • Klinik für Neurochirurgie, Kantonsspital St. Gallen

    collaborator UNKNOWN
  • Klinik für Neurochirurgie, Universitätsspital Zürich

    collaborator UNKNOWN
  • Primario Neurologia, EOC Ospedale Regionale di Lugano - Civico e Italiano

    collaborator UNKNOWN
  • Abteilung für Neuropsychologie, Klinik für Neurologie, Kantonsspital St.Gallen

    collaborator UNKNOWN
  • Abteilung für Neuropsychologie, Klinik für Neurologie, Universitätsspital Zürich

    collaborator UNKNOWN
  • Département des Neurosciences cliniques, Service de Neurochirurgie, CHUV, Lausanne

    collaborator UNKNOWN
  • Département des Neurosciences cliniques, Service de Neurologie, CHUV, Lausanne

    collaborator UNKNOWN
  • Département des Neurosciences cliniques, Service de Neurologie, Hôpitaux Universitaires de Genève

    collaborator UNKNOWN
  • Swiss SOS Study Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-20
Primary Completion
2022-05-06
Completion
2022-05-06

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03032471 on ClinicalTrials.gov